Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 2023-07-26 (2 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: TREMBLAY-EN-FRANCE (93290), Seine-Saint-Denis
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELAS PHARMACIE DE L'ALLIANCE : revenue, balance sheet and financial ratios
SELAS PHARMACIE DE L'ALLIANCE is a French company
founded 2 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in TREMBLAY-EN-FRANCE (93290),
this company of category PME
shows in 2024 a net income negative of -71 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE DE L'ALLIANCE (SIREN 980433312)
Indicator
2024
Revenue
N/C
Net income
-71 328 €
EBITDA
N/C
Net margin
N/C
Revenue and income statement
In 2024, SELAS PHARMACIE DE L'ALLIANCE records a net loss of 71 k€. This deficit will reduce equity on the balance sheet.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-71 328 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at -1235%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -8%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
-1235.242%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
-7.612%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELAS PHARMACIE DE L'ALLIANCE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2024
Debt ratio
-1235.242
Financial autonomy
-7.612
Repayment capacity
None
Cash flow / Revenue
None%
Sector positioning
Debt ratio
-1235.242024
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of SELAS PHARMACIE DE L'ALLI... (-1235.24) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
-7.61%2024
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch
In 2024, the financial autonomy of SELAS PHARMACIE DE L'ALLI... (-7.6%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 176.10. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
176.105
Liquidity indicators evolution SELAS PHARMACIE DE L'ALLIANCE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2024
Liquidity ratio
176.105
Interest coverage
None
Sector positioning
Liquidity ratio
176.12024
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average
In 2024, the liquidity ratio of SELAS PHARMACIE DE L'ALLI... (176.10) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of SELAS PHARMACIE DE L'ALLIANCE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE DE L'ALLIANCE with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE DE L'ALLIANCE
What is the revenue of SELAS PHARMACIE DE L'ALLIANCE ?
The revenue of SELAS PHARMACIE DE L'ALLIANCE is not publicly disclosed (confidential accounts filed with INPI).
Is SELAS PHARMACIE DE L'ALLIANCE profitable?
SELAS PHARMACIE DE L'ALLIANCE recorded a net loss in 2024.
Where is the headquarters of SELAS PHARMACIE DE L'ALLIANCE ?
The headquarters of SELAS PHARMACIE DE L'ALLIANCE is located in TREMBLAY-EN-FRANCE (93290), in the department Seine-Saint-Denis.
Where to find the tax return of SELAS PHARMACIE DE L'ALLIANCE ?
The tax return of SELAS PHARMACIE DE L'ALLIANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE DE L'ALLIANCE operate?
SELAS PHARMACIE DE L'ALLIANCE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart